Cancer Research

Can Rytvela Prevent Preterm Birth by Targeting Inflammation?
Research & Development Can Rytvela Prevent Preterm Birth by Targeting Inflammation?

The global medical community currently faces a staggering crisis as approximately 13.5 million infants are born prematurely every year, representing one of the most significant hurdles in modern obstetrics and neonatal care. This phenomenon is not merely a statistical concern; it is a leading cause

AI-Driven Neuro-Oncology Diagnostics – Review
Research & Development AI-Driven Neuro-Oncology Diagnostics – Review

The long-standing reliance on high-risk surgical biopsies for brain tumor classification is finally yielding to a more sophisticated era of computational molecular profiling. This transition represents a fundamental shift in how the medical community perceives diagnostic data, moving from the

Does Mental Health Impact Survival After a Cancer Diagnosis?
Research & Development Does Mental Health Impact Survival After a Cancer Diagnosis?

A person’s psychological state during a medical crisis is often treated as a secondary concern, yet for those facing a cancer diagnosis, the invisible weight of the mind might be as consequential as the cellular battle within. Recent clinical evidence suggests that the emotional fallout of such a

Can mcPCR Solve the DNA Methylation Bottleneck?
Research & Development Can mcPCR Solve the DNA Methylation Bottleneck?

The molecular diagnostics industry is currently witnessing a tectonic shift as clinicians move beyond simple genetic sequencing to embrace the complex, data-rich landscape of the epigenome. While identifying specific mutations remains a cornerstone of oncology, the ability to detect DNA methylation

The Rise of Anxiety Medication Faces MAHA Movement Backlash
Research & Development The Rise of Anxiety Medication Faces MAHA Movement Backlash

Matthias Aizenberg and Ivan Kairatov discuss the shifting landscape of American mental health, focusing on the nearly 38 million adults now utilizing anxiety medications. As a biopharma expert with a deep background in research and development, Kairatov provides a clinical perspective on why

Screening Boosts Survival for Advanced Breast Cancer
Research & Development Screening Boosts Survival for Advanced Breast Cancer

A diagnosis of advanced, metastatic breast cancer has long been viewed as a grim final chapter, but groundbreaking research reveals that the simple act of attending a routine screening can dramatically rewrite the ending for many women. This isn't just about catching cancer early; it's about

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later